THE PROBLEM45% of Americans suffer from at least one chronic disease. The biological processes of chronic diseases, however, progresses over decades. In fact, patients presenting common symptoms of fatigue or dizziness may be early evidence of a serious underlying condition. However, it takes an average of 2-4 years to properly diagnose these severe diseases, preventing the early disease treatment. THE SOLUTIONWe have developed a test that uses metabolites in the blood, combined with artificial intelligence (AI) to quickly identify what diseases are present for earlier diagnosis and treatment. AI identifies the diseases that are present by recognizing patterns in the patient’s circulating metabolites providing a quick result to the doctor and patient. We have patented these patterns as “disease fingerprints” and are the first in the field to use such a novel approach.
| Website | https://www.metfora.com |
| Employees | 7 (3 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology |
| Keywords | Metabolic Health, Diabetes Management, Chronic Disease Prevention, Precision Medicine, Personalized Health, Disease Prediction, Data-Driven Healthcare, Digital Health Solutions, Virtual Care, Health Tech, Health Optimization, Patient Engagement, Health Coaching, Lifestyle Modification, Population Health Management, Predictive Health Analytics, Wellness Programs, Health Risk Assessment, Remote Patient Monitoring, Telehealth Platform |
| Competitors | Squarespace, Salesforce, Shopify, Wix.com, BigCommerce, WooCommerce, Magento2 Developer Community, PrestaShop +36 more (view full list) |
Looking for a particular Metfora employee's phone or email?
Martin Fuchs is the Cofounder and CEO of Metfora.
3 people are employed at Metfora.
Metfora is based in Tucson, Arizona.